Zobrazeno 1 - 10
of 260
pro vyhledávání: '"Ar, Lehmann"'
Publikováno v:
Europe PubMed Central
Xeroderma pigmentosum (XP)-C is one of the more common complementation groups of XP, but causative mutations have thus far been reported for only six cases (S. G. Khan et al., J. Investig. Dermatol., 115: 791-796, 1998; L. Li et al., Nat. Genet., 5:
Publikováno v:
Europe PubMed Central
We have developed a DNA-based system, to detect mutations at restriction sites without any selection in culture. DNA is exhaustively digested with a restriction enzyme. Primers flanking a chosen site for this enzyme are used in the polymerase chain r
Autor:
Ar, Lehmann, Anne Willis, Bc, Broughton, James MR, Steingrimsdottir H, Sa, Harcourt, Cf, Arlett, Lindahl T
Publikováno v:
Europe PubMed Central
46BR is a human fibroblast strain derived from an immunodeficient young female of stunted growth. The diploid fibroblasts as well as a Simian Virus 40-transformed cell line are hypersensitive to killing by many DNA-damaging agents, exhibit a slightly
Autor:
Zabrady K, Adamus M, Vondrova L, Liao C, Skoupilova H, Novakova M, Jurcisinova L, Alt A, Antony Oliver, Ar, Lehmann, Jj, Palecek
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2ded116d9295ef578567b935e93986fe
http://europepmc.org/abstract/med/26446992
http://europepmc.org/abstract/med/26446992
Autor:
Garcia-Moreno H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK., Langbehn DR; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA., Abiona A; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Garrood I; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Fleszar Z; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK., Manes MA; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK., Morley AMS; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.; Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Craythorne E; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Mohammed S; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Henshaw T; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Turner S; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Naik H; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Bodi I; Clinical Neuropathology, Academic Neuroscience Building, King's College Hospital, London SE5 9RS, UK., Sarkany RPE; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Fassihi H; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK., Lehmann AR; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, UK., Giunti P; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.; UK National Xeroderma Pigmentosum Service, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, UK.
Publikováno v:
Brain : a journal of neurology [Brain] 2023 Dec 01; Vol. 146 (12), pp. 5044-5059.
Autor:
Stafki SA; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Turner J; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Littel HR; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Bruels CC; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Truong D; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Knirsch U; Neuromuscular Center Zürich and Department of Pediatric Neurology, University Children's Hospital Zürich, University of Zürich, Zürich, Switzerland., Stettner GM; Neuromuscular Center Zürich and Department of Pediatric Neurology, University Children's Hospital Zürich, University of Zürich, Zürich, Switzerland., Graf U; Institute of Medical Molecular Genetics (IMMG), University of Zürich, Zürich, Switzerland., Berger W; Institute of Medical Molecular Genetics (IMMG), University of Zürich, Zürich, Switzerland; Neuroscience Center Zurich (NCZ), University and ETH Zürich, Zürich, Switzerland; Zürich Center for Integrative Human Physiology (ZIHP), University of Zürich, Zürich, Switzerland., Kinali M; Department of Brain Sciences, Imperial College London and Portland Hospital HCA International, London, United Kingdom., Jungbluth H; Evelina Children's Hospital and King's College London, University of Manchester, London, United Kingdom., Pacak CA; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota., Hughes J; Amy and Friends Cockayne Syndrome/Trichothiodystrophy Support, Wirral, United Kingdom., Mirchi A; Departments of Neurology and Neurosurgery and Pediatrics, McGill University, Montreal, Canada; Child Health and Human Development Program, Research Institute of the McGill University Health Center, Montreal, Canada., Derksen A; Departments of Neurology and Neurosurgery and Pediatrics, McGill University, Montreal, Canada; Child Health and Human Development Program, Research Institute of the McGill University Health Center, Montreal, Canada., Vincent-Delorme C; Department of Clinical Genetics, Hôpital Jeanne de Flandre, CHU Lille, Lille, France., Theil AF; Department of Molecular Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Bernard G; Departments of Neurology and Neurosurgery and Pediatrics, McGill University, Montreal, Canada; Child Health and Human Development Program, Research Institute of the McGill University Health Center, Montreal, Canada; Department of Human Genetics, McGill University, Montreal, Canada; Division of Medical Genetics, Department Specialized Medicine, McGill University Health Center, Montreal, Canada., Ellis D; South East Genomics Laboratory Hub, Guy's Hospital, London, United Kingdom., Fassihi H; St. John's Institute of Dermatology, Rare Disease Centre, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Lehmann AR; Genome Damage and Stability Centre, University of Sussex, Brighton, United Kingdom., Laugel V; Service de Pédiatrie 1, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Laboratoire de Génétique médicale, INSERM U1112, Institut de génétique médicale d'Alsace, Faculté de Médecine de Strasbourg, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Mohammed S; South East Thames Regional Genetics Service and Rare Diseases Centre Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Kang PB; Department of Neurology and Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota; Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota. Electronic address: pkang@umn.edu.
Publikováno v:
Pediatric neurology [Pediatr Neurol] 2023 Apr; Vol. 141, pp. 79-86. Date of Electronic Publication: 2023 Jan 24.
Autor:
Abiona A; National Xeroderma Pigmentosum Service, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom aabiona@nhs.net., Cordeiro N; Paediatric Neurodisability Service, Rainbow House, Ayrshire Central Hospital, Irvine, NHS Ayrshire and Arran, Scotland, United Kingdom., Fawcett H; Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, United Kingdom., Tamura D; DNA Repair Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Khan SG; DNA Repair Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., DiGiovanna JJ; DNA Repair Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Lehmann AR; Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, United Kingdom., Fassihi H; National Xeroderma Pigmentosum Service, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Pediatrics [Pediatrics] 2021 Oct; Vol. 148 (4). Date of Electronic Publication: 2021 Sep 30.
Autor:
Botta E; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Theil AF; Department of Molecular Genetics, Oncode Institute, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands., Raams A; Department of Molecular Genetics, Oncode Institute, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands., Caligiuri G; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Giachetti S; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Bione S; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Accadia M; Medical Genetics Service, Hospital 'Cardinale G. Panico', Via San Pio X Tricase 73039, Italy., Lombardi A; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Smith DEC; Metabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam 1081 HZ, The Netherlands., Mendes MI; Metabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam 1081 HZ, The Netherlands., Swagemakers SMA; Department of Pathology, Clinical Bioinformatics Unit, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands., van der Spek PJ; Department of Pathology, Clinical Bioinformatics Unit, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands., Salomons GS; Metabolic Unit, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam Gastroenterology & Metabolism, Amsterdam 1081 HZ, The Netherlands.; Laboratory of Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands., Hoeijmakers JHJ; Department of Molecular Genetics, Oncode Institute, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands.; Oncode Institute, Princess Maxima Center for Pediatric Oncology, Utrecht 3584 CS, The Netherlands.; Institute for Genome Stability in Ageing and Disease, CECAD Forschungszentrum, University of Cologne, Cologne 50931, Germany., Yesodharan D; Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, AIMS Ponekkara PO, Cochin 682041, Kerala, India., Nampoothiri S; Department of Pediatric Genetics, Amrita Institute of Medical Sciences & Research Centre, AIMS Ponekkara PO, Cochin 682041, Kerala, India., Ogi T; Department of Genetics, Research Institute of Environmental Medicine (RIEM), Nagoya University, Nagoya 464-8601, Japan.; Department of Human Genetics and Molecular Biology, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan., Lehmann AR; Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Famer, Brighton BN1 9RQ, UK., Orioli D; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza' (IGM) CNR, Via Abbiategrasso 207, Pavia 27100, Italy., Vermeulen W; Department of Molecular Genetics, Oncode Institute, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2021 Aug 28; Vol. 30 (18), pp. 1711-1720.
Autor:
Lehmann AR; Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK. Electronic address: a.r.lehmann@sussex.ac.uk., Fassihi H; National Xeroderma Pigmentosum Service, Guy's and St Thomas' Foundation Trust, London SE1 9RT, UK.
Publikováno v:
DNA repair [DNA Repair (Amst)] 2020 Sep; Vol. 93, pp. 102907.
Autor:
Cipolla L; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza', CNR, Pavia, Italy., Bertoletti F; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza', CNR, Pavia, Italy., Maffia A; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza', CNR, Pavia, Italy., Liang CC; Department of Biochemistry, University of Oxford, Oxford, UK., Lehmann AR; Genome Damage and Stability Centre, University of Sussex, Brighton, UK., Cohn MA; Department of Biochemistry, University of Oxford, Oxford, UK., Sabbioneda S; Istituto di Genetica Molecolare 'Luigi Luca Cavalli-Sforza', CNR, Pavia, Italy.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2019 Dec 02; Vol. 47 (21), pp. 11268-11283.